Edition:
United States

NanoCarrier Co Ltd (4571.T)

4571.T on Tokyo Stock Exchange

665JPY
28 Apr 2017
Change (% chg)

¥-6 (-0.89%)
Prev Close
¥671
Open
¥667
Day's High
¥669
Day's Low
¥662
Volume
186,700
Avg. Vol
373,918
52-wk High
¥1,820
52-wk Low
¥618

Latest Key Developments (Source: Significant Developments)

NanoCarrier to invest into Tocagen
Monday, 24 Apr 2017 02:01am EDT 

April 24(Reuters) - NanoCarrier Co Ltd <4571.T>:Says it will invest into Tocagen Inc <<>>.  Full Article

NanoCarrier decides to resume phase III clinical trial of NC-6004
Thursday, 20 Apr 2017 01:46am EDT 

April 20 (Reuters) - NanoCarrier Co Ltd <4571.T> ::* Says it decides to resume phase III clinical trial of NC-6004 .  Full Article

NanoCarrier signs joint research agreement with University of Utah
Friday, 7 Apr 2017 03:43am EDT 

NanoCarrier Co Ltd <4571.T> : Says it signed joint research agreement with Pharmaceutical Chemistry group (professor You H. Bae) of The University of Utah (U of U) on April 3 .Says the company and the university will cooperate on research of oral delivery of protein.  Full Article

NanoCarrier forms cooperation with TPG Biologics Inc. on joint research
Thursday, 23 Mar 2017 01:14am EDT 

NanoCarrier Co Ltd <4571.T>:Says the co formed cooperation with TPG Biologics Inc., a unit of Taiwan-based firm Center Laboratories Inc.<4123.TWO>, on joint research.  Full Article

NanoCarrier decides to terminate clinical trial of NC-6004
Wednesday, 21 Dec 2016 04:11am EST 

NanoCarrier Co Ltd <4571.T> :Says it decides to terminate the first phase of clinical trial for NC-6004.  Full Article

NanoCarrier says patent for nucleic acid delivery technology granted by European Patent Office
Monday, 1 Aug 2016 12:11am EDT 

NanoCarrier Co Ltd <4571.T>:Says patent related to nucleic acid delivery technology granted by the European Patent Office regarding particle composition and pharmaceutical composition.  Full Article

NanoCarrier says clinical trial of NC-6004
Tuesday, 21 Jun 2016 10:55pm EDT 

NanoCarrier Co Ltd <4571.T>:Says it submitted CTA (Clinical Trial Authorization) of NC-6004 to regulatory authorities of EU regional.  Full Article

NanoCarrier receives patent recognition in U.S
Sunday, 3 Apr 2016 10:30pm EDT 

NanoCarrier Co Ltd:Received patent recognition from United States Patent and Trademark Office, for particle composition as well as its pharmaceutical composition.  Full Article

NanoCarrier enters new development agreement with ALBION
Wednesday, 23 Mar 2016 10:30pm EDT 

NanoCarrier Co Ltd:Enters a new development agreement with ALBION co.,ltd., to cooperate on joint development of products in skin related area.  Full Article

NanoCarrier signs license agreement with Tokyo-based company
Tuesday, 15 Mar 2016 11:35pm EDT 

NanoCarrier Co Ltd:Says signed exclusive license contract with sub-licenses right with a Tokyo-based company regarding the company's gene delivery technology.Says the Tokyo-based company engaged in research and development of pharmaceuticals by using drug delivery system.  Full Article

More From Around the Web

BRIEF- NanoCarrier to invest into Tocagen

April 24NanoCarrier Co Ltd * Says it will invest into Tocagen Inc Source text in Japanese:https://goo.gl/zfV0hp Further company coverage: (Beijing Headline News)